Glucocorticoid treatment increases cholesterol availability during critical illness: effect on adrenal and muscle function
Glucocorticoid treatment partially attenuated critical illness-induced hypocholesterolemia, but at a cost of impaired adrenal function, suppressed muscle regeneration and exacerbated loss of body mass.
Authors
- Lies Pauwels
- Tim Van Oudenhove
- Greet De Vlieger (ORCID: https://orcid.org/0000-0002-6579-6965)
- Sarah Derde (ORCID: https://orcid.org/0009-0005-6724-643X)
- Sarah Vander Perre
- Lies Langouche (ORCID: https://orcid.org/0000-0002-8564-6809)
- Inge Derese
- Lauren De Bruyn (ORCID: https://orcid.org/0000-0002-5036-3403)
- Greet Van den Berghe (ORCID: https://orcid.org/0000-0002-5320-1362)
- Arno Téblick (ORCID: https://orcid.org/0000-0001-8829-0855)
Institutions
- KU Leuven (BE)
Publication Details
- Journal
- Critical Care
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1186/s13054-024-05079-8
- Citations
- 6
- Primary Topic
- Adrenal Hormones and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.15
Funders
- European Commission
- Fonds Wetenschappelijk Onderzoek
- KU Leuven
- Vlaamse regering
- European Research Council